These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16258002

  • 1. Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen.
    Vayalil PK, Olman M, Murphy-Ullrich JE, Postlethwait EM, Liu RM.
    Am J Physiol Lung Cell Mol Physiol; 2005 Dec; 289(6):L937-45. PubMed ID: 16258002
    [Abstract] [Full Text] [Related]

  • 2. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.
    Vayalil PK, Iles KE, Choi J, Yi AK, Postlethwait EM, Liu RM.
    Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1281-92. PubMed ID: 17890327
    [Abstract] [Full Text] [Related]

  • 3. Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
    Huang Y, Border WA, Lawrence DA, Noble NA.
    Kidney Int; 2006 Aug; 70(3):515-22. PubMed ID: 16788698
    [Abstract] [Full Text] [Related]

  • 4. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 5. Plasmin is not protective in experimental renal interstitial fibrosis.
    Edgtton KL, Gow RM, Kelly DJ, Carmeliet P, Kitching AR.
    Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling.
    Pedroja BS, Kang LE, Imas AO, Carmeliet P, Bernstein AM.
    J Biol Chem; 2009 Jul 31; 284(31):20708-17. PubMed ID: 19487690
    [Abstract] [Full Text] [Related]

  • 7. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
    Haraguchi M, Border WA, Huang Y, Noble NA.
    Kidney Int; 2001 Jun 31; 59(6):2146-55. PubMed ID: 11380816
    [Abstract] [Full Text] [Related]

  • 8. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL, Tuszynski GP.
    Cancer; 1995 Sep 15; 76(6):998-1005. PubMed ID: 8625226
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
    Krag S, Danielsen CC, Carmeliet P, Nyengaard J, Wogensen L.
    Kidney Int; 2005 Dec 15; 68(6):2651-66. PubMed ID: 16316341
    [Abstract] [Full Text] [Related]

  • 10. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May 15; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 11. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.
    Kidney Int; 2005 May 15; 67(5):1762-71. PubMed ID: 15840023
    [Abstract] [Full Text] [Related]

  • 12. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells.
    Kagami S, Kuhara T, Okada K, Kuroda Y, Border WA, Noble NA.
    Kidney Int; 1997 Mar 15; 51(3):664-71. PubMed ID: 9067897
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts.
    Cao HJ, Hogg MG, Martino LJ, Smith TJ.
    Invest Ophthalmol Vis Sci; 1995 Jun 15; 36(7):1411-9. PubMed ID: 7775119
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.
    Horowitz JC, Rogers DS, Simon RH, Sisson TH, Thannickal VJ.
    Am J Respir Cell Mol Biol; 2008 Jan 15; 38(1):78-87. PubMed ID: 17656680
    [Abstract] [Full Text] [Related]

  • 15. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J, van Oeveren W.
    Thromb Res; 1998 Nov 15; 92(4):171-9. PubMed ID: 9840026
    [Abstract] [Full Text] [Related]

  • 16. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, Birkedal-Hansen H, Bugge TH.
    J Biol Chem; 2002 Nov 22; 277(47):45154-61. PubMed ID: 12192005
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.
    Davis GE, Pintar Allen KA, Salazar R, Maxwell SA.
    J Cell Sci; 2001 Mar 22; 114(Pt 5):917-30. PubMed ID: 11181175
    [Abstract] [Full Text] [Related]

  • 18. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD, Moore HB, Kong YW, Chapman MP, Sriram G, Lim D, Moore EE, Yaffe MB.
    J Trauma Acute Care Surg; 2019 Jan 22; 86(1):101-107. PubMed ID: 30575685
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 22; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 20. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
    Albo D, Berger DH, Vogel J, Tuszynski GP.
    J Gastrointest Surg; 1999 Aug 22; 3(4):411-7. PubMed ID: 10482694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.